Masses in the anterior mediastinum can be neoplasms (eg, thymomas, thymic carcinomas, or lung metastases) or non-neoplastic conditions (eg, intrathoracic goiter). Thymomas are the most common primary tumor in the anterior mediastinum, although they are rare. Thymic carcinomas are very rare. Thymomas and thymic carcinomas originate in the thymus. Although thymomas can spread locally, they are much less invasive than thymic carcinomas. Patients with thymomas have 5-year survival rates of approximately 78%. However, 5-year survival rates for thymic carcinomas are only approximately 40%. These guidelines outline the evaluation, treatment, and management of these mediastinal tumors.

  • 1.

    Proceedings of the First International Conference on Thymic Malignancies. August 20-21, 2009. Bethesda, Maryland, USA. J Thorac Oncol2010;5:S259370.

    • Search Google Scholar
    • Export Citation
  • 2.

    StrolloDCRosado de ChristensonMLJettJR. Primary mediastinal tumors. Part 1: tumors of the anterior mediastinum. Chest1997;112:511522.

    • Search Google Scholar
    • Export Citation
  • 3.

    EngelsEAPfeifferRM. Malignant thymoma in the United States: demographic patterns in incidence and associations with subsequent malignancies. Int J Cancer2003;105:546551.

    • Search Google Scholar
    • Export Citation
  • 4.

    MasaokaA. Staging system of thymoma. J Thorac Oncol2010;5:S304312.

  • 5.

    KondoKMondenY. Therapy for thymic epithelial tumors: a clinical study of 1,320 patients from Japan. Ann Thorac Surg2003;76:878884; discussion 884-875.

    • Search Google Scholar
    • Export Citation
  • 6.

    EngTYFullerCDJagirdarJ. Thymic carcinoma: state of the art review. Int J Radiat Oncol Biol Phys2004;59:654664.

  • 7.

    MarchevskyAMarxAStrobelP. Policies and reporting guidelines for small biopsy specimens of mediastinal masses. J Thorac Oncol2011;6:S17241729.

    • Search Google Scholar
    • Export Citation
  • 8.

    StrolloDCRosado-de-ChristensonMLJettJR. Primary mediastinal tumors: part II. Tumors of the middle and posterior mediastinum. Chest1997;112:13441357.

    • Search Google Scholar
    • Export Citation
  • 9.

    DetterbeckFCParsonsAM. Management of stage I and II thymoma. Thorac Surg Clin2011;21:5967vi-vii.

  • 10.

    BarthTFELeithäuserFJoosS. Mediastinal (thymic) large B-cell lymphoma: where do we stand?Lancet Oncol2002;3:229234.

  • 11.

    FerollaPFalchettiAFilossoP. Thymic neuroendocrine carcinoma (carcinoid) in multiple endocrine neoplasia type 1 syndrome: the Italian series. J Clin Endocrinol Metab2005;90:26032609.

    • Search Google Scholar
    • Export Citation
  • 12.

    TehBT. Thymic carcinoids in multiple endocrine neoplasia type 1. J Intern Med1998;243:501504.

  • 13.

    MaromEM. Imaging thymoma. J Thorac Oncol2010;5:S296303.

  • 14.

    Rosado-de-ChristensonMLStrolloDCMaromEM. Imaging of thymic epithelial neoplasms. Hematol Oncol Clin North Am2008;22:409431.

  • 15.

    SadoharaJFujimotoKMullerNL. Thymic epithelial tumors: comparison of CT and MR imaging findings of low-risk thymomas, high-risk thymomas, and thymic carcinomas. Eur J Radiol2006;60:7079.

    • Search Google Scholar
    • Export Citation
  • 16.

    MaromEMRosado-de-ChristensonMLBruzziJF. Standard report terms for chest computed tomography reports of anterior mediastinal masses suspicious for thymoma. J Thorac Oncol2011;6:S17171723.

    • Search Google Scholar
    • Export Citation
  • 17.

    AberleDRAdamsAMBergCD. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med2011;365:395409.

  • 18.

    SungYMLeeKSKimBT. 18F-FDG PET/CT of thymic epithelial tumors: usefulness for distinguishing and staging tumor subgroups. J Nucl Med2006;47:16281634.

    • Search Google Scholar
    • Export Citation
  • 19.

    RuffiniEVan RaemdonckDDetterbeckF. Management of thymic tumors: a survey of current practice among members of the European Society of Thoracic Surgeons. J Thorac Oncol2011;6:614623.

    • Search Google Scholar
    • Export Citation
  • 20.

    KondoK. Optimal therapy for thymoma. J Med Invest2008;55:1728.

  • 21.

    DetterbeckFCParsonsAM. Thymic tumors. Ann Thorac Surg2004;77:18601869.

  • 22.

    WrightCD. Stage IVA thymoma: patterns of spread and surgical management. Thorac Surg Clin2011;21:9397vii.

  • 23.

    WrightCD. Extended resections for thymic malignancies. J Thorac Oncol2010;5:S344347.

  • 24.

    HuangJRizkNPTravisWD. Feasibility of multimodality therapy including extended resections in stage IVA thymoma. J Thorac Cardiovasc Surg2007;134:14771483; discussion 1483-1484.

    • Search Google Scholar
    • Export Citation
  • 25.

    TokerASonettJZielinskiM. Standard terms, definitions, and policies for minimally invasive resection of thymoma. J Thorac Oncol2011;6:S17391742.

    • Search Google Scholar
    • Export Citation
  • 26.

    PennathurAQureshiISchuchertMJ. Comparison of surgical techniques for early-stage thymoma: feasibility of minimally invasive thymectomy and comparison with open resection. J Thorac Cardiovasc Surg2011;141:694701.

    • Search Google Scholar
    • Export Citation
  • 27.

    KomanapalliCBCohenJISukumarMS. Extended transcervical video-assisted thymectomy. Thorac Surg Clin2010;20:235243.

  • 28.

    LimmerKKKernstineKH. Minimally invasive and robotic-assisted thymus resection. Thorac Surg Clin2011;21:6983vii.

  • 29.

    DetterbeckFCNicholsonAGKondoK. The Masaoka-Koga stage classification for thymic malignancies: clarification and definition of terms. J Thorac Oncol2011;6:S17101716.

    • Search Google Scholar
    • Export Citation
  • 30.

    HuangJDetterbeckFCWangZLoehrerPJSr.Standard outcome measures for thymic malignancies. J Thorac Oncol2011;6:S16911697.

  • 31.

    MoranCAWalshGSusterSKaiserL. Thymomas II: a clinicopathologic correlation of 250 cases with a proposed staging system with emphasis on pathologic assessment. Am J Clin Pathol2012;137:451461.

    • Search Google Scholar
    • Export Citation
  • 32.

    KondoK. Tumor-node metastasis staging system for thymic epithelial tumors. J Thorac Oncol2010;5:S352356.

  • 33.

    LeeHSKimSTLeeJ. A single institutional experience of thymic epithelial tumours over 11 years: clinical features and outcome and implications for future management. Br J Cancer2007;97:2228.

    • Search Google Scholar
    • Export Citation
  • 34.

    MasaokaAMondenYNakaharaKTaniokaT. Follow-up study of thymomas with special reference to their clinical stages. Cancer1981;48:24852492.

    • Search Google Scholar
    • Export Citation
  • 35.

    WrightCD. Management of thymomas. Crit Rev Oncol Hematol2008;65:109120.

  • 36.

    TravisWBrambillaEMuller-HermelinkHHarrisC. Pathology and genetics of tumours of the lung pleura thymus and heart. WHO Classification of Tumors3rd ed.Lyon: IARC Press; 2004:145197.

    • Search Google Scholar
    • Export Citation
  • 37.

    LewisJEWickMRScheithauerBW. Thymoma. A clinicopathologic review. Cancer1987;60:27272743.

  • 38.

    ParkHSShinDMLeeJS. Thymoma. A retrospective study of 87 cases. Cancer1994;73:24912498.

  • 39.

    KondoKYoshizawaKTsuyuguchiM. WHO histologic classification is a prognostic indicator in thymoma. Ann Thorac Surg2004;77:11831188.

  • 40.

    MoranCAWeissferdtAKalhorN. Thymomas I: a clinicopathologic correlation of 250 cases with emphasis on the World Health Organization schema. Am J Clin Pathol2012;137:444450.

    • Search Google Scholar
    • Export Citation
  • 41.

    MarxARiekerRTokerA. Thymic carcinoma: is it a separate entity? From molecular to clinical evidence. Thorac Surg Clin2011;21:2531v-vi.

    • Search Google Scholar
    • Export Citation
  • 42.

    MargaritoraSCesarioACusumanoG. Thirty-five-year follow-up analysis of clinical and pathologic outcomes of thymoma surgery. Ann Thorac Surg2010;89:245252; discussion 252.

    • Search Google Scholar
    • Export Citation
  • 43.

    RegnardJFMagdeleinatPDromerC. Prognostic factors and long-term results after thymoma resection: a series of 307 patients. J Thorac Cardiovasc Surg1996;112:376384.

    • Search Google Scholar
    • Export Citation
  • 44.

    YanoMSasakiHYokoyamaT. Thymic carcinoma: 30 cases at a single institution. J Thorac Oncol2008;3:265269.

  • 45.

    OgawaKToitaTUnoT. Treatment and prognosis of thymic carcinoma: a retrospective analysis of 40 cases. Cancer2002;94:31153119.

  • 46.

    OkerekeICKeslerKAFreemanRK. Thymic carcinoma: outcomes after surgical resection. Ann Thorac Surg2012;93:16681672; discussion 1672-1673.

    • Search Google Scholar
    • Export Citation
  • 47.

    DetterbeckFYoussefSRuffiniEOkumuraM. A review of prognostic factors in thymic malignancies. J Thorac Oncol2011;6:S1698–-1704.

  • 48.

    MehranRGhoshRMaziakD. Surgical treatment of thymoma. Can J Surg2002;45:2530.

  • 49.

    MurakawaTNakajimaJKohnoT. Results from surgical treatment for thymoma. 43 years of experience. Jpn J Thorac Cardiovasc Surg2000;48:8995.

    • Search Google Scholar
    • Export Citation
  • 50.

    WakelyPEJr.Fine needle aspiration in the diagnosis of thymic epithelial neoplasms. Hematol Oncol Clin North Am2008;22:433442.

  • 51.

    DetterbeckFCMoranCHuangJ. Which way is up? Policies and procedures for surgeons and pathologists regarding resection specimens of thymic malignancy. J Thorac Oncol2011;6:S17301738.

    • Search Google Scholar
    • Export Citation
  • 52.

    GilhusNEOweJFHoffJM. Myasthenia gravis: a review of available treatment approaches. Autoimmune Dis2011;2011:847393.

  • 53.

    Autoantibodies to acetylcholine receptors in myasthenia gravis. N Engl J Med1983;308:402403.

  • 54.

    HowardFMLennonVAFinleyJ. Clinical correlations of antibodies that bind, block, or modulate human acetylcholine receptors in myasthenia gravis. Ann N Y Acad Sci1987;505:526538.

    • Search Google Scholar
    • Export Citation
  • 55.

    UtsumiTShionoHKadotaY. Postoperative radiation therapy after complete resection of thymoma has little impact on survival. Cancer2009;115:54135420.

    • Search Google Scholar
    • Export Citation
  • 56.

    KorstRJKanslerALChristosPJMandalS. Adjuvant radiotherapy for thymic epithelial tumors: a systematic review and meta-analysis. Ann Thorac Surg2009;87:16411647.

    • Search Google Scholar
    • Export Citation
  • 57.

    ForquerJARongNFakirisAJ. Postoperative radiotherapy after surgical resection of thymoma: differing roles in localized and regional disease. Int J Radiat Oncol Biol Phys2010;76:440445.

    • Search Google Scholar
    • Export Citation
  • 58.

    RuffiniEMancusoMOliaroA. Recurrence of thymoma: analysis of clinicopathologic features, treatment, and outcome. J Thorac Cardiovasc Surg1997;113:5563.

    • Search Google Scholar
    • Export Citation
  • 59.

    GomezDKomakiRYuJ. Radiation therapy definitions and reporting guidelines for thymic malignancies. J Thorac Oncol2011;6:S17431748.

  • 60.

    GomezDKomakiR. Technical advances of radiation therapy for thymic malignancies. J Thorac Oncol2010;5:S336343.

  • 61.

    HartfordACPaliscaMGEichlerTJ. American Society for Therapeutic Radiology and Oncology (ASTRO) and American College of Radiology (ACR) Practice Guidelines for Intensity-Modulated Radiation Therapy (IMRT). Int J Radiat Oncol Biol Phys2009;73:914.

    • Search Google Scholar
    • Export Citation
  • 62.

    MoranJMDempseyMEisbruchA. Safety considerations for IMRT: executive summary. Med Phys2011;38:50675072.

  • 63.

    GregoireVMackieTR. State of the art on dose prescription, reporting and recording in intensity-modulated radiation therapy (ICRU report No. 83). Cancer Radiother2011;15:555559.

    • Search Google Scholar
    • Export Citation
  • 64.

    HolmesTDasRLowD. American Society of Radiation Oncology recommendations for documenting intensity-modulated radiation therapy treatments. Int J Radiat Oncol Biol Phys2009;74:13111318.

    • Search Google Scholar
    • Export Citation
  • 65.

    KongFMPanCEisbruchATen HakenRK. Physical models and simpler dosimetric descriptors of radiation late toxicity. Semin Radiat Oncol2007;17:108120.

    • Search Google Scholar
    • Export Citation
  • 66.

    MilanoMTConstineLSOkunieffP. Normal tissue tolerance dose metrics for radiation therapy of major organs. Semin Radiat Oncol2007;17:131140.

    • Search Google Scholar
    • Export Citation
  • 67.

    MyojinMChoiNCWrightCD. Stage III thymoma: pattern of failure after surgery and postoperative radiotherapy and its implication for future study. Int J Radiat Oncol Biol Phys2000;46:927933.

    • Search Google Scholar
    • Export Citation
  • 68.

    MornexFResbeutMRichaudP. Radiotherapy and chemotherapy for invasive thymomas: a multicentric retrospective review of 90 cases. The FNCLCC trialists. Federation Nationale des Centres de Lutte Contre le Cancer. Int J Radiat Oncol Biol Phys1995;32:651659.

    • Search Google Scholar
    • Export Citation
  • 69.

    SinghalSShragerJBRosenthalDI. Comparison of stages I-II thymoma treated by complete resection with or without adjuvant radiation. Ann Thorac Surg2003;76:16351641; discussion 1641-1642.

    • Search Google Scholar
    • Export Citation
  • 70.

    RenaOPapaliaEOliaroA. Does adjuvant radiation therapy improve disease-free survival in completely resected Masaoka stage II thymoma?Eur J Cardiothorac Surg2007;31:109113.

    • Search Google Scholar
    • Export Citation
  • 71.

    MangiAAWrightCDAllanJS. Adjuvant radiation therapy for stage II thymoma. Ann Thorac Surg2002;74:10331037.

  • 72.

    SugieCShibamotoYIkeya-HashizumeC. Invasive thymoma: postoperative mediastinal irradiation, and low-dose entire hemithorax irradiation in patients with pleural dissemination. J Thorac Oncol2008;3:7581.

    • Search Google Scholar
    • Export Citation
  • 73.

    OgawaKUnoTToitaT. Postoperative radiotherapy for patients with completely resected thymoma: a multi-institutional, retrospective review of 103 patients. Cancer2002;94:14051413.

    • Search Google Scholar
    • Export Citation
  • 74.

    CowenDRichaudPMornexF. Thymoma: results of a multicentric retrospective series of 149 non-metastatic irradiated patients and review of the literature. FNCLCC trialists. Federation Nationale des Centres de Lutte Contre le Cancer. Radiother Oncol1995;34:916.

    • Search Google Scholar
    • Export Citation
  • 75.

    GirardNLalRWakeleeH. Chemotherapy definitions and policies for thymic malignancies. J Thorac Oncol2011;6:S17491755.

  • 76.

    GirardN. Chemotherapy and targeted agents for thymic malignancies. Expert Rev Anticancer Ther2012;12:685695.

  • 77.

    LoehrerPJSr.ChenMKimK. Cisplatin, doxorubicin, and cyclophosphamide plus thoracic radiation therapy for limited-stage unresectable thymoma: an Intergroup trial. J Clin Oncol1997;15:30933099.

    • Search Google Scholar
    • Export Citation
  • 78.

    LoehrerPJKimKAisnerSC. Cisplatin plus doxorubicin plus cyclophosphamide in metastatic or recurrent thymoma: final results of an intergroup trial. The Eastern Cooperative Oncology Group, Southwest Oncology Group, and Southeastern Cancer Study Group. J Clin Oncol1994;12:11641168.

    • Search Google Scholar
    • Export Citation
  • 79.

    GiacconeGArdizzoniAKirkpatrickA. Cisplatin and etoposide combination chemotherapy for locally advanced or metastatic thymoma. A phase II study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group. J Clin Oncol1996;14:814820.

    • Search Google Scholar
    • Export Citation
  • 80.

    ShinDMWalshGLKomakiR. A multidisciplinary approach to therapy for unresectable malignant thymoma. Ann Intern Med1998;129:100104.

  • 81.

    FornasieroADanieleOGhiottoC. Chemotherapy for invasive thymoma. A 13-year experience. Cancer1991;68:3033.

  • 82.

    LoehrerPJJiroutekMAisnerS. Combined etoposide, ifosfamide, and cisplatin in the treatment of patients with advanced thymoma and thymic carcinoma: an intergroup trial. Cancer2001;91:20102015.

    • Search Google Scholar
    • Export Citation
  • 83.

    KimESPutnamJBKomakiR. Phase II study of a multidisciplinary approach with induction chemotherapy, followed by surgical resection, radiation therapy, and consolidation chemotherapy for unresectable malignant thymomas: final report. Lung Cancer2004;44:369379.

    • Search Google Scholar
    • Export Citation
  • 84.

    LucchiMMelfiFDiniP. Neoadjuvant chemotherapy for stage III and IVA thymomas: a single-institution experience with a long follow-up. J Thorac Oncol2006;1:308313.

    • Search Google Scholar
    • Export Citation
  • 85.

    YokoiKMatsugumaHNakaharaR. Multidisciplinary treatment for advanced invasive thymoma with cisplatin, doxorubicin, and methylprednisolone. J Thorac Oncol2007;2:7378.

    • Search Google Scholar
    • Export Citation
  • 86.

    LemmaGLLoehrerPJSr.LeeJW. A phase II study of carboplatin plus paclitaxel in advanced thymoma or thymic carcinoma: E1C99 [abstract]. J Clin Oncol2008;26(Suppl 15):Abstract 8018.

    • Search Google Scholar
    • Export Citation
  • 87.

    VenutaFRendinaEALongoF. Long-term outcome after multimodality treatment for stage III thymic tumors. Ann Thorac Surg2003;76:18661872; discussion 1872.

    • Search Google Scholar
    • Export Citation
  • 88.

    RajanAGiacconeG. Chemotherapy for thymic tumors: induction, consolidation, palliation. Thorac Surg Clin2011;21:107114viii.

  • 89.

    SchmittJLoehrerPJSr.The role of chemotherapy in advanced thymoma. J Thorac Oncol2010;5:S357360.

  • 90.

    LemmaGLLeeJWAisnerSC. Phase II study of carboplatin and paclitaxel in advanced thymoma and thymic carcinoma. J Clin Oncol2011;29:20602065.

    • Search Google Scholar
    • Export Citation
  • 91.

    FurugenMSekineITsutaK. Combination chemotherapy with carboplatin and paclitaxel for advanced thymic cancer. Jpn J Clin Oncol2011;41:10131016.

    • Search Google Scholar
    • Export Citation
  • 92.

    RielyGJHuangJ. Induction therapy for locally advanced thymoma. J Thorac Oncol2010;5:S323326.

  • 93.

    WrightCDChoiNCWainJC. Induction chemoradiotherapy followed by resection for locally advanced Masaoka stage III and IVA thymic tumors. Ann Thorac Surg2008;85:385389.

    • Search Google Scholar
    • Export Citation
  • 94.

    LongoFDe FilippisLZiviA. Efficacy and tolerability of long-acting octreotide in the treatment of thymic tumors: results of a pilot trial. Am J Clin Oncol2012;35:105109.

    • Search Google Scholar
    • Export Citation
  • 95.

    LoehrerPJSr.WangWJohnsonDH. Octreotide alone or with prednisone in patients with advanced thymoma and thymic carcinoma: an Eastern Cooperative Oncology Group Phase II Trial. J Clin Oncol2004;22:293299.

    • Search Google Scholar
    • Export Citation
  • 96.

    PalmieriGMerolaGFedericoP. Preliminary results of phase II study of capecitabine and gemcitabine (CAP-GEM) in patients with metastatic pretreated thymic epithelial tumors (TETs). Ann Oncol2010;21:11681172.

    • Search Google Scholar
    • Export Citation
  • 97.

    HighleyMSUnderhillCRParnisFX. Treatment of invasive thymoma with single-agent ifosfamide. J Clin Oncol1999;17:27372744.

  • 98.

    PanCCChenPCWangLS. Thymoma is associated with an increased risk of second malignancy. Cancer2001;92:24062411.

  • 99.

    SusterSRosaiJ. Thymic carcinoma. A clinicopathologic study of 60 cases. Cancer1991;67:10251032.

  • 100.

    HuangJRizkNPTravisWD. Comparison of patterns of relapse in thymic carcinoma and thymoma. J Thorac Cardiovasc Surg2009;138:2631.

  • 101.

    StrobelPHohenbergerPMarxA. Thymoma and thymic carcinoma: molecular pathology and targeted therapy. J Thorac Oncol2010;5:S286290.

  • 102.

    MoranCASusterS. Thymic carcinoma: current concepts and histologic features. Hematol Oncol Clin North Am2008;22:393407.

  • 103.

    HosakaYTsuchidaMToyabeS. Masaoka stage and histologic grade predict prognosis in patients with thymic carcinoma. Ann Thorac Surg2010;89:912917.

    • Search Google Scholar
    • Export Citation
  • 104.

    BlumbergDBurtMEBainsMS. Thymic carcinoma: current staging does not predict prognosis. J Thorac Cardiovasc Surg1998;115:303308; discussion 308-309.

    • Search Google Scholar
    • Export Citation
  • 105.

    MaruyamaRSuemitsuROkamotoT. Persistent and aggressive treatment for thymic carcinoma. Results of a single-institute experience with 25 patients. Oncology2006;70:325329.

    • Search Google Scholar
    • Export Citation
  • 106.

    WeideLGUlbrightTMLoehrerPJWilliamsSD. Thymic carcinoma. A distinct clinical entity responsive to chemotherapy. Cancer1993;71:12191223.

    • Search Google Scholar
    • Export Citation
  • 107.

    LucchiMMussiAAmbrogiM. Thymic carcinoma: a report of 13 cases. Eur J Surg Oncol2001;27:636640.

  • 108.

    YohKGotoKIshiiGI. Weekly chemotherapy with cisplatin, vincristine, doxorubicin, and etoposide is an effective treatment for advanced thymic carcinoma. Cancer2003;98:926931.

    • Search Google Scholar
    • Export Citation
  • 109.

    IgawaSMurakamiHTakahashiT. Efficacy of chemotherapy with carboplatin and paclitaxel for unresectable thymic carcinoma. Lung Cancer2010;67:194197.

    • Search Google Scholar
    • Export Citation
  • 110.

    KoizumiTTakabayashiYYamagishiS. Chemotherapy for advanced thymic carcinoma: clinical response to cisplatin, doxorubicin, vincristine, and cyclophosphamide (ADOC chemotherapy). Am J Clin Oncol2002;25:266268.

    • Search Google Scholar
    • Export Citation
  • 111.

    KandaSKoizumiTKomatsuY. Second-line chemotherapy of platinum compound plus CPT-11 following ADOC chemotherapy in advanced thymic carcinoma: analysis of seven cases. Anticancer Res2007;27:30053008.

    • Search Google Scholar
    • Export Citation
  • 112.

    KomatsuYKoizumiTTanabeT. Salvage chemotherapy with carboplatin and paclitaxel for cisplatin-resistant thymic carcinoma—three cases. Anticancer Res2006;26:48514855.

    • Search Google Scholar
    • Export Citation
  • 113.

    OkumaYShimokawaTTakagiY. S-1 is an active anticancer agent for advanced thymic carcinoma. Lung Cancer2010;70:357363.

  • 114.

    KoizumiTAgatsumaTKomatsuYKuboK. Successful S-1 monotherapy for chemorefractory thymic carcinoma. Anticancer Res2011;31:299301.

  • 115.

    StrobelPBargouRWolffA. Sunitinib in metastatic thymic carcinomas: laboratory findings and initial clinical experience. Br J Cancer2010;103:196200.

    • Search Google Scholar
    • Export Citation
  • 116.

    BisagniGRossiGCavazzaA. Long lasting response to the multikinase inhibitor bay 43-9006 (Sorafenib) in a heavily pretreated metastatic thymic carcinoma. J Thorac Oncol2009;4:773775.

    • Search Google Scholar
    • Export Citation
  • 117.

    StrobelPHartmannMJakobA. Thymic carcinoma with overexpression of mutated KIT and the response to imatinib. N Engl J Med2004;350:26252626.

    • Search Google Scholar
    • Export Citation
  • 118.

    GirardN. Targeted therapies for thymic malignancies. Thorac Surg Clin2011;21:115123viii.

All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 327 326 38
PDF Downloads 105 105 6
EPUB Downloads 0 0 0